Lv71
5000 积分 2023-06-01 加入
Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer
7天前
已完结
Quantitative (18)F-FDG PET/CT Model for predicting pathological complete response to neoadjuvant immunochemotherapy in NSCLC: comparison with RECIST 1.1 and PERCIST
1个月前
已完结
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
3个月前
已完结
Pathological Response and Nodal Status Guide Adjuvant Immunotherapy in NSCLC After Neoadjuvant Chemoimmunotherapy: An Eastern Asian Cohort Study
5个月前
已完结
Combination of Radiotherapy and Immunotherapy in Advanced Non–Small Cell Lung Cancer
5个月前
已完结
Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy
6个月前
已完结
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH)
6个月前
已完结
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
7个月前
已完结
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer
10个月前
已完结
IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
10个月前
已完结
皖公网安备34019202002308
